Evidence map›Paper›PMID 35529989›Full record

ArticleRSC advances2019

Chemodivergent synthesis of

Yanpeng Liu, Lixue Lu, Haipin Zhou, Feijie Xu, Cong Ma, Zhangjian Huang, Jinyi Xu, Shengtao Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. KRSC advances · 2023
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yanpeng LiuState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.
Lixue LuState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.
Haipin ZhouCollege of Materials & Chemical Engineering, Chuzhou University Chuzhou 239000 China.
Feijie XuState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.
Cong MaState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University Kowloon Hong Kong SAR P. R. China.ORCID https://orcid.org/0000-0001-9245-0356
Zhangjian HuangState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.ORCID https://orcid.org/0000-0001-6409-8535
Jinyi XuState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.ORCID https://orcid.org/0000-0002-1961-0402
Shengtao XuState Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China jinyixu@china.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35529989
PMCPMC9073897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.